Neonatal PCP is more potent than ketamine at modifying preweaning behaviors of sprague-dawley rats

Toxicological Sciences

Volumn 106, Issue 1, 2008, Pages 172-179

  Boctor, Sherin Y ^a,b   Wang, Cheng ^a,b   Ferguson, Sherry A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Forelimb hang; Ketamine; Negative geotaxis; Neurodegeneration; Phencyclidine; Pup behavior

Indexed keywords

CARNITINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FORELIMB; LATENT PERIOD; MALE; MOTOR COORDINATION; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PARESIS; PERINATAL PERIOD; RAT; WEANING;

AGING; ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; BEHAVIOR, ANIMAL; BODY WEIGHT; CARNITINE; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, SUBCUTANEOUS; KETAMINE; MOTOR ACTIVITY; NERVOUS SYSTEM; NEUROPROTECTIVE AGENTS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS; RODENTIA;

EID: 54349105449     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn152     Document Type: Article

References (39)

1. Adams, J., Buelke-Sam, J., Kimmel, C. A., Nelson, C. J., Reiter, L. W., Sobotka, T. J., Tilson, H. A., and Nelson, B. K. (1985). Collaborative Behavioral Teratology Study: Protocol design and testing procedures. Neurobehav. Toxicol. Teratol. 7, 579-586.
2. Barron, S., and Riley, E. P. (1985). Pup-induced maternal behavior in adult and juvenile rats exposed to alcohol prenatally. Alcohol Clin. Exp. Res. 9, 360-365.
3. Brunson, K. L., Khanna, A., Cromwell, H. C., and Cohen, R. W. (2001). Effect of the noncompetitive NMDA antagonists MK-801 and ketamine on the spastic Han-Wistar mutant: A rat model of excitotoxicity. Dev. Neurosci. 23, 31-40.
4. Cada, A. M., Gray, E. P., and Ferguson, S. A. (2000). Minimal behavioral effects from developmental cerebellar stunting in young rats induced by postnatal treatment with alpha-difluoromethylornithine. Neurotoxicol. Teratol. 22, 415-420.
5. Chen, G., Ensor, C. R., Russell, D., and Bohner, B. (1959). The pharmacology of 1-(1-phenylcyclohexyl) piperidine-HCl. J. Pharmacol. Exp. Ther. 127, 241-250.
6. Edwards, S. R., Minto, C. F., and Mather, L. E. (2002). Concurrent ketamine and alfentanil administration: Pharmacokinetic considerations. Br. J. Anaesth. 88, 94-100.
7. Felipo, V., Minana, M. D., Cabedo, H., and Grisolia, S. (1994). L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity. Neurochem. Res. 19, 373-377.
8. Ferguson, S. A., Gray, E. P., and Cada, A. M. (2003). Early behavioral development in the spontaneously hypertensive rat: A comparison with the Wistar-Kyoto and Sprague-Dawley strains. Behav. Neurosci. 117 263-270.
9. Fleming, A. S., O'Day, D. H., and Kraemer, G. W. (1999). Neurobiology of mother-infant interactions: Experience and central nervous system plasticity across development and generations. Neurosci. Biobehav. Rev. 23, 673-685.
10. Goodwin, G. A., and Barr, G. A. (2005). Developmental changes in the behavioral and autonomic effects of kappa opioid receptor stimulation of the midbrain periaqueductal gray. Dev. Psychobiol. 46, 47-56.
11. Hagen, T. M., Moreau, R., Suh, J. H., and Visioli, F. (2002). Mitochondrial decay in the aging rat heart: Evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann. N. Y. Acad. Sci. 959, 491-507.
12. Harris, L. W., Sharp, T., Gartlon, J., Jones, D. N., and Harrison, P. J. (2003). Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur. J. Neurosci. 18, 1706-1710.
13. Hayashi, H., Dikkes, P., and Soriano, S. G. (2002). Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr. Anaesth. 12, 770-774.
14. Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vockler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., and Olney, J. W. (1999). Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283, 70-74.
15. Kakizawa, S., Yamasaki, M., Watanabe, M., and Kano, M. (2000). Critical period for activity-dependent synapse elimination in developing cerebellum. J. Neurosci. 20, 4954-4961.
16. Kawabe, K., Iwasaki, T., and Ichitani, Y. (2007). Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes longterm deficits of radial-arm maze learning. Brain Res. 1169, 77-86.
17. Marino, M. D., Cronise, K., Lugo, J. N., Jr., and Kelly, S. J. (2002). Ultrasonic vocalizations and maternal-infant interactions in a rat model of fetal alcohol syndrome. Dev. Psychobiol. 41, 341-351.
18. Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J. Nutr. 130, 1007S-1015S.
19. Monti, B., and Contestabile, A. (2000). Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum. Eur. J. Neurosci. 12 3117-3123.
20. National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
21. Rothstein, S., Simkins, T., and Nunez, J. L. (2008). Response to neonatal anesthesia: Effect of sex on anatomical and behavioral outcome. Neuroscience 152, 959-969.
22. Rudin, M., Ben-Abraham, R., Gazit, V., Tendler, Y., Tashlykov, V., and Katz, Y. (2005). Single-dose ketamine administration induces apoptosis in neonatal mouse brain. J. Basic Clin. Physiol. Pharmacol. 16 231-243.
23. Scallet, A. C., Schmued, L. C., Slikker, W., Jr., Grunberg, N., Faustino, P. J., Davis, H., Lester, D., Pine, P. S., Sistare, F., and Hanig, J. P. (2004). Developmental neurotoxicity of ketamine: Morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 81, 364-370.
24. Shelnutt, S. R., Gunnell, M., and Owens, S. M. (1999). Sexual dimorphism in phencyclidine in vitro metabolism and pharmacokinetics in rats. J. Pharmacol. Exp. Ther. 290, 1292-1298.
25. Sircar, R. (2003). Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int. J. Dev. Neurosci. 21, 159-167.
26. Sircar, R., and Rudy, J. W. (1998). Repeated neonatal phencyclidine treatment impairs performance of a spatial task in juvenile rats. Ann. N. Y. Acad. Sci. 844, 303-309.
27. Sturgeon, R. D., Fessler, R. G., and Meltzer, H. Y. (1979). Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 59 169-179.
28. Wang, C., McInnis, J., Ross-Sanchez, M., Shinnick-Gallagher, P., Wiley, J. L., and Johnson, K. M. (2001). Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: Implications for schizophrenia. Neuroscience 107, 535-550.
29. Wang, C., Sadovova, N., Ali, H. K., Duhart, H. M., Fu, X., Zou, X., Patterson, T. A., Binienda, Z. K., Virmani, A., et al. (2007). L-carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture. Neuroscience 144 46-55.
30. Wang, C. Z., and Johnson, K. M. (2005). Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat. J. Neurosci. Res. 81, 284-292.
31. Wiley, J. L., Buhler, K. G., Lavecchia, K. L., and Johnson, K. M. (2003). Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 867-873.
32. Williams, M. L., Mager, D. E., Parenteau, H., Gudi, G., Tracy, T. S., Mulheran, M., and Wainer, I. W. (2004). Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats. Drug Metab. Dispos. 32, 786-793.
33. Wolff, K., and Winstock, A. R. (2006). Ketamine: From medicine to misuse. CNS Drugs 20, 199-218.
34. Wood, K. A., Dipasquale, B., and Youle, R. J. (1993). In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 11, 621-632.
35. Xie, H., Tang, S. Y., Li, H., Luo, X. H., Yuan, L. Q., Wang, D., and Liao, E. Y. (2007). L: - Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids. doi:10.1007/ s00726-007-0598-9.
36. Yoon, W. J., Won, S. J., Ryu, B. R., and Gwag, B. J. (2003). Blockade of ionotropic glutamate receptors produces neuronal apoptosis through the Baxcytochrome C-caspase pathway: The causative role of Ca2+ deficiency. J. Neurochem. 85, 525-533.
37. Young, C., Jevtovic-Todorovic, V., Qin, Y. Q., Tenkova, T., Wang, H., Labruyere, J., and Olney, J. W. (2005). Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br. J. Pharmacol. 146, 189-197.
38. Zissen, M. H., Zhang, G., McKelvy, A., Propst, J. T., Kendig, J. J., and Sweitzer, S. M. (2007). Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats. Neuroscience 144, 247-262.
39. Zou, X., Sadovova, N., Patterson, T. A., Divine, R. L., Hotchkiss, C. E., Ali, S. F., Hanig, J. P., Paule, M. G., Slikker, W., Jr., and Wang, C. (2008). The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex. Neuroscience 151, 1053-1065.